1. Home
  2. ETNB vs EVTC Comparison

ETNB vs EVTC Comparison

Compare ETNB & EVTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • EVTC
  • Stock Information
  • Founded
  • ETNB 2018
  • EVTC 1988
  • Country
  • ETNB United States
  • EVTC United States
  • Employees
  • ETNB N/A
  • EVTC N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • EVTC EDP Services
  • Sector
  • ETNB Health Care
  • EVTC Technology
  • Exchange
  • ETNB Nasdaq
  • EVTC Nasdaq
  • Market Cap
  • ETNB 2.2B
  • EVTC 1.9B
  • IPO Year
  • ETNB 2019
  • EVTC 2013
  • Fundamental
  • Price
  • ETNB $14.80
  • EVTC $31.06
  • Analyst Decision
  • ETNB Buy
  • EVTC Hold
  • Analyst Count
  • ETNB 10
  • EVTC 5
  • Target Price
  • ETNB $22.31
  • EVTC $39.00
  • AVG Volume (30 Days)
  • ETNB 3.5M
  • EVTC 373.3K
  • Earning Date
  • ETNB 11-07-2025
  • EVTC 11-05-2025
  • Dividend Yield
  • ETNB N/A
  • EVTC 0.64%
  • EPS Growth
  • ETNB N/A
  • EVTC 102.95
  • EPS
  • ETNB N/A
  • EVTC 2.13
  • Revenue
  • ETNB N/A
  • EVTC $886,589,000.00
  • Revenue This Year
  • ETNB N/A
  • EVTC $9.23
  • Revenue Next Year
  • ETNB N/A
  • EVTC $4.84
  • P/E Ratio
  • ETNB N/A
  • EVTC $14.55
  • Revenue Growth
  • ETNB N/A
  • EVTC 12.93
  • 52 Week Low
  • ETNB $4.16
  • EVTC $29.38
  • 52 Week High
  • ETNB $15.06
  • EVTC $38.56
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 75.79
  • EVTC 41.20
  • Support Level
  • ETNB $14.74
  • EVTC $30.20
  • Resistance Level
  • ETNB $14.85
  • EVTC $30.95
  • Average True Range (ATR)
  • ETNB 0.06
  • EVTC 0.70
  • MACD
  • ETNB -0.20
  • EVTC 0.09
  • Stochastic Oscillator
  • ETNB 33.33
  • EVTC 56.54

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. It derives maximum revenue from Latin America Payments and Solutions. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.

Share on Social Networks: